We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$96.1B
1-Year Est. Return
40.06%
This Fund
S&P 500
This Quarter
Est. Return
+7.4%
1 Year Est. Return
+40.06%
3 Year Est. Return
+122.14%
5 Year Est. Return
+169.19%
10 Year Est. Return
+659.21%
AUM
$96.3B
AUM Growth
-$417M
(-0.43%)
Cap. Flow
-$13.2B
Cap. Flow
% of AUM
-13.72%
Top 10 Holdings %
Top 10 Hldgs %
26.4%
Holding
2,844
New
49
Increased
603
Reduced
1,950
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$495M |
| 2 |
Wells Fargo
WFC
|
+$454M |
| 3 |
Salesforce
CRM
|
+$405M |
| 4 |
BA.PRA
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
|
+$327M |
| 5 |
Constellation Energy
CEG
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$387M |
| 2 |
Apple
AAPL
|
+$378M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Palo Alto Networks
PANW
|
+$359M |
| 5 |
Zscaler
ZS
|
+$284M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.56% |
| 2 | Financials | 9.84% |
| 3 | Consumer Discretionary | 9.4% |
| 4 | Healthcare | 8.11% |
| 5 | Communication Services | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Lyell Immunopharma
LYEL
$365M
| $33.9K | ﹤0.01% |
2,647
-130
| -5% | -$2.58K |
|
2602
Editas Medicine
EDIT
$453M
| $33.4K | ﹤0.01% |
26,325
-1,936
| -7% | -$4.93K |
|
2603
Cabaletta Bio
CABA
$455M
| $32.2K | ﹤0.01% |
14,202
-702
| -5% | -$2.46K |
|
|
LNAI
2604
Lunai Bioworks
LNAI
$10.9M
| $29.5K | ﹤0.01% |
+441
| New | +$29.3K |
|
|
FLNA
2605
Filana Therapeutics
FLNA
$46.9M
| $28.9K | ﹤0.01% |
12,255
-1,007
| -8% | -$17.7K |
|
2606
Lexicon Pharmaceuticals
LXRX
$1.08B
| $28.4K | ﹤0.01% |
38,418
| – | – |
|
2607
Aemetis
AMTX
$123M
| $28.3K | ﹤0.01% |
+10,527
| New | +$33.1K |
|
2608
Veru
VERU
$47.6M
| $27.7K | ﹤0.01% |
4,260
-367
| -8% | -$2.72K |
|
2609
Black Diamond Therapeutics
BDTX
$120M
| $26.4K | ﹤0.01% |
12,326
-974
| -7% | -$2.79K |
|
2610
Tenaya Therapeutics
TNYA
$168M
| $26.1K | ﹤0.01% |
18,259
-1,275
| -7% | -$2.86K |
|
|
APLT
2611
DELISTED
Applied Therapeutics
APLT
| $24.9K | ﹤0.01% |
29,115
-2,758
| -9% | -$17.3K |
|
2612
Pyxis Oncology
PYXS
$179M
| $24.8K | ﹤0.01% |
15,897
-1,302
| -8% | -$3.75K |
|
2613
Lineage Cell Therapeutics
LCTX
$283M
| $19.5K | ﹤0.01% |
38,835
-17,951
| -32% | -$13.2K |
|
2614
Precigen
PGEN
$2.46B
| $17K | ﹤0.01% |
15,138
-34,402
| -69% | -$29.3K |
|
|
GBIO
2615
DELISTED
Generation Bio
GBIO
| $12.4K | ﹤0.01% |
1,169
-551
| -32% | -$9.82K |
|
2616
Stem
STEM
$52.8M
| $10.3K | ﹤0.01% |
857
-2,205
| -72% | -$19K |
|
2617
ALX Oncology
ALXO
$267M
| – | – |
-12,813
| Closed | -$23.3K |
|
|
GOLD
2618
Gold.com Inc
GOLD
$1.26B
| – | – |
-5,998
| Closed | -$265K |
|
2619
AnaptysBio
ANAB
$1.71B
| – | – |
-6,602
| Closed | -$221K |
|
2620
Anika Therapeutics
ANIK
$284M
| – | – |
-9,960
| Closed | -$246K |
|
|
JBIO
2621
Jade Biosciences
JBIO
$1.42B
| – | – |
-1,876
| Closed | -$137K |
|
2622
Bar Harbor Bankshares
BHB
$667M
| – | – |
-6,586
| Closed | -$203K |
|
|
BLUE
2623
DELISTED
bluebird bio
BLUE
| – | – |
-3,295
| Closed | -$34.2K |
|
2624
Bridgewater Bancshares
BWB
$605M
| – | – |
-10,231
| Closed | -$145K |
|
2625
Cass Information Systems
CASS
$736M
| – | – |
-5,125
| Closed | -$213K |
|
Similar funds
VOYA Investment Management's Q4 2024 Portfolio in Review
As of Q4 2024, VOYA Investment Management held 2,844 positions worth $96.3B, down 0.43% from $96.7B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
VOYA Investment Management withdrew a net $13.2B in Q4 2024, closing 111 positions and reducing 1,950 holdings. Its most notable exit was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $62.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, VOYA Investment Management opened a new position in Boeing Co 6.00% Series A Preferred Stock worth $353M.
- VOYA Investment Management's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 5,799,930 shares worth $353M.
- VOYA Investment Management added most to Atlassian in Q4 2024, an estimated $495M increase.
- VOYA Investment Management's biggest Q4 2024 reduction was Tesla, cutting an estimated $387M.
- VOYA Investment Management fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2024, selling an estimated $62.1M.
- VOYA Investment Management's ten largest holdings make up 26% of its $96.3B portfolio in Q4 2024.
- VOYA Investment Management opened 49 new positions and closed 111 in Q4 2024.
- VOYA Investment Management's portfolio value fell 0.43% quarter-over-quarter to $96.3B.
Based on VOYA Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.